Cowan Elvia

CIK 00019600481 companySAN CARLOS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001960048

Recent Transactions

45 trades

Sale
Vaxcyte, Inc.$PCVX
Common Stock
2026-03-17$55.39/sh−1,487→ 29,380 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2026-03-17$56.26/sh−405→ 28,975 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2026-03-11$58.59/sh−2,500→ 30,867 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2026-03-11$25.92/sh+2,500→ 33,367 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2026-03-11−2,500→ 96,068 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2026-03-09$59.32/sh−495→ 30,867 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2026-03-02$61.98/sh−326→ 31,362 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2026-02-28$61.98/sh−243→ 31,688 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2026-02-26−7,716→ 98,568 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2026-02-26+10,681→ 24,215 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2026-02-26$25.92/sh+7,716→ 31,931 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2026-02-26+17,855→ 17,855 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-08$32.41/sh−482→ 26,156 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-07+2,810→ 27,205 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-02$31.56/sh−242→ 26,963 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-09-02$31.56/sh−325→ 26,638 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-08-29+9,743→ 9,743 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-03-03$72.10/sh−325→ 24,106 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-28$73.02/sh−242→ 24,431 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2025-02-27+5,379→ 24,673 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2025-02-27+17,961→ 17,961 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-12-16$25.92/sh+7,716→ 19,294 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-12-16−7,716→ 106,284 total
Award
Vaxcyte, Inc.$PCVX
Performance Stock Option (right to buy)
2024-11-07+11,900→ 11,900 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-03$107.67/sh−5,000→ 12,723 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-03$25.92/sh+5,000→ 17,723 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-09-03−5,000→ 114,000 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2024-09-03$110.15/sh−1,145→ 11,578 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-07-16$25.92/sh+5,000→ 17,723 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-07-16−5,000→ 119,000 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-07-16$85.00/sh−5,000→ 12,723 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-07-08$25.92/sh+5,000→ 17,723 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-07-08$80.00/sh−5,000→ 12,723 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-07-08−5,000→ 124,000 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2024-03-02$71.55/sh−324→ 12,156 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-03-01−11,000→ 129,000 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-03-01$73.08/sh−2,322→ 21,836 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-03-01$74.90/sh−4,901→ 12,480 total
Sale
Vaxcyte, Inc.$PCVX
Common Stock
2024-03-01$73.69/sh−4,455→ 17,381 total
Exercise/Conversion
Vaxcyte, Inc.$PCVX
Common Stock
2024-03-01$25.92/sh+11,000→ 24,158 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2024-02-29+25,000→ 25,000 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2024-02-29+5,400→ 13,158 total
Tax Payment
Vaxcyte, Inc.$PCVX
Common Stock
2023-09-05$51.00/sh−627→ 7,301 total
Award
Vaxcyte, Inc.$PCVX
Stock Option (right to buy)
2023-03-01+43,500→ 43,500 total
Award
Vaxcyte, Inc.$PCVX
Common Stock
2023-03-01+7,250→ 7,250 total

Companies

Vaxcyte, Inc.
SVP, Finance & CAO
$PCVX

Recent Filings

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300

SAN CARLOS, CA, 94070

View on SEC.gov